Marya Postner is head of Cooley's life sciences partnering practice. Marya represents public and private life sciences companies in a variety of complex transactions including collaborations, license agreements, options to license or purchase, territory-specific licenses, joint venture and other profit-sharing arrangements, co-promotion relationships, and manufacture and supply agreements. She counsels clients with respect to the structuring and negotiation of agreements designed to maximize the value of the company's products and technology assets. She has particular expertise handling strategic alliances between biotechnology and pharmaceutical companies in areas as diverse as collaborative research and the development and marketing of late-stage pharmaceutical products.

Download full bio 


  • Forbius Agrees to Sell to Bristol Myers Squibb 

  • Sangamo Announces Global Collaboration with Novartis 

  • Sangamo Announces Global Licensing Collaboration Agreement with Biogen 

  • Jazz Pharma Announces Exclusive License Agreement with PharmaMar 

  • Iconic Therapeutics Announces Option and License Agreement with Exelixis 

  • View all


  • University of California, Berkeley School of Law
    JD, 1996

  • Princeton University
    PhD, Molecular Biology

  • Princeton University
    MA, Molecular Biology

  • Georgetown University
    BS, Biology
    magna cum laude, 1987

Admissions & Credentials


Registered to practice before the United States Patent & Trademark Office (USPTO)


  • American Bar Association

  • Sigma Xi

  • American Association for the Advancement of Science

Rankings & Accolades

    Chambers USA: Life Sciences: Corporate/Commercial – California

    Legal 500: Healthcare: Life Sciences “Key Lawyer”

    LMG Life Sciences: Finance & Transactional “Star”

    Best Lawyers in America: Biotechnology Law

    IAM Patent 1000: Go-to for Biotech and Biopharmaceutical Companies

    Who’s Who of Legal

“respected transactional practice counseling life sciences companies in a broad range of matters, including licensing, joint ventures and collaborations”

"There is no one better at drafting in the industry."

Chambers USA: Life Sciences: Corporate/Commercial – California (2022)